← Browse by Condition
Medical Condition
arrhythmogenic right ventricular cardiomyopathy
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2
NCT03049254
Recruiting
Mayo AVC Registry and Biobank
Enrollment
1,000 pts
Location
United States, Unite...
Sponsor
Mayo Clinic
NCT06228924 Phase 1
Recruiting
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Enrollment
15 pts
Location
United States
Sponsor
Tenaya Therapeutics
NCT06174220 Phase 2
Recruiting
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
Enrollment
120 pts
Location
Canada
Sponsor
Hamilton Health Sciences Corpo...